Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects

Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Lower Limb Spasticity in Japanese Subjects

ObjectiveTo confirm the efficacy and safety of incobotulinumtoxinA (Xeomin®, Merz Pharmaceuticals GmbH; total dose 400 U) in Japanese subjects with lower limb (LL) poststroke spasticity using the Modified Ashworth Scale spasticity score for the plantar flexors (MAS-PF).MethodsThis phase III study (J...

Full description

Bibliographic Details
Main Authors: Yoshihisa Masakado, Hitoshi Kagaya, Kunitsugu Kondo, Yohei Otaka, Andrzej Dekundy, Angelika Hanschmann, Thorin L. Geister, Ryuji Kaji
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-03-01
Series:Frontiers in Neurology
Subjects:
botulinum neurotoxin type A
incobotulinumtoxinA
treatment
spasticity
lower limb
Japan
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.832937/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.832937/full

Similar Items